For site information, send an email with site number to
Investigational Site Number 8400026(6.7 mi away)Contact
+53 other location
The primary objective of this study is to demonstrate the non-inferiority of the vaccine
seroresponse to meningococcal serogroups A, C, Y, and W following administration of 2 doses
of MenACYW conjugate vaccine compared to 2 doses of MENVEO when given concomitantly with
routine pediatric vaccines to infants and toddlers 6 to 7 months of age and 12 to 13 months
The secondary objective is to demonstrate the non-inferiority of the percentage of subjects
with antibody titers to meningococcal serogroups A, C, Y, and W 1:8 following
administration of 2 doses of MenACYW conjugate vaccine compared to 2 doses of MENVEO when
given concomitantly with pediatric routine vaccines to infants and toddlers at 6 to 7 months
of age and 12 to 13 months of age.
The study also includes as an observational objective to describe the safety profile of
MenACYW conjugate vaccine and MENVEO when administered concomitantly with routine pediatric
vaccines in healthy infants and toddlers.
Study duration per participant is approximately 1 year in Group 1 and Group 2, and 10 months
in Group 3 and Group 4. This duration includes a safety follow-up contact at 6 months after
the last vaccination.
Hepatitis B vaccine,
Pneumococcal 13-valent Conjugate Vaccine,
Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine,
Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine,
Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine,
Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine,
Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine,
Haemophilus b Conjugate Vaccine,
Rotavirus Vaccine, Live, Oral, Pentavalent,
Measles, Mumps, and Rubella Virus Vaccine Live,
Varicella Virus Vaccine Live
Clinical Study Identifier
Sanofi Pasteur, a Sanofi Company
Last Modified on
29 November 2020
How clear was the trial content above?
Adding a note
Select a piece of text and start making personal notes.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.